25
DAFTAR PUSTAKA
Badiee, P., Alborzi, A., Moeini, M., Haddadi., P., Farshad, S., Japoni, A., et al., 2012, Antifungal Susceptibility of the Aspergillus Species by Etest and CLSI Reference Methods, Archives of Iranian Medicine, 15 (7).
Clark, G., Kasten, F. H. & Conn, H. J., 1983, History of staining, Williams & Wilkins, Philadelphia, United States.
Deacon, J. W., 2006, Fungal Biology, sixth edition, 21-23, Blackwell Publishing Ltd., Victoria, Australia.
Ellis, D. & Herman, R., 2003, Mold Pictures: Aspergillus fumigatus, http://www.mold.ph/aspergillus-fumigatus.htm (diakses tanggal 29 Januari 2014).
Ellis, M., Frampton, C., Joseph, J., Alizadeh, H., Kristensen, J., Hauggard, A., et al., 2006, An open study of the comparative efficacy and safety of caspofungin and liposomal amphotericin B in treating invasive fungal infections or febrile neutropenia in patients with haematological malignancy, Journal of Medical Microbiology, 55, 1357–1365.
Fortu’n, J., Martin-Da ‘Villa, P., Montejo, M., Munoz, P., Cineros, JM., Ramos, A., et al., 2009, Prophylaxis With Caspofungin for Invasive Fungal Infections in High-Risk Liver Transplant Recipients, Clincal And Translational Research, 87 (3), 424-434.
Fothergill, A. W., 2012, Antifungal Susceptibility Testing: Clinical Laboratory and Standards Institute (CLSI) Methods, LLC, Springer Science & Business Media.
Ghannoum, M. A. & Rice, L. B., 1999, Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance, Clinical Microbiology Reviews, 12 (4).
Hilado, A. L. E., 2005, Mold Pictures: Aspergillus fumigatus, http://www.mold.ph/aspergillus-fumigatus.htm (diakses tanggal 29 Januari 2014).
Henrici, A.T., 1948, The Biology of Bacteria, D.C.Heath and Company, Houghton Mifflin, United States.
26
Ingroff, E., Skaggs, A., Iqbal, E., Pfaller, M.S., Rinaldi, M., Fothergill, A., et al., 2007, Multicenter Evaluation of a New Disk Agar Diffusion Method for Susceptibility Testing of Filamentous Fungi with Voriconazole, Posaconazole, Itraconazole, Amphotericin B, and Caspofungin, Journal of Clinical Microbiology, 45 (6).
Jawetz, E., Melnick, J. & Adelberg, E., 1996, Mikrobiologi Kedokteran, Jakarta, EGC.
Jawetz, M. & Adelberg, E., 2007, Medical Microbiology, USA, The Mc.Graw-Hill Companies Inc.
Johnson, E.M., Szekely, A. & Warnock, D.W., 1998, In-vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi, Journal of Antimicrobial Chemotherapy, 42.
Karthaus, M., 2011, Prophylaxis and Treatment of Invasive Aspergillosis with Voriconazole, Posaconazole, and Caspofungin, European Journal of Medical Research, 16, 145-152.
Kee, Joyce L. & Hayes, Evelyn R., 1996, Farmakologi: Pendekatan Proses Keperawatan, Jakarta, EGC.
Kuzucu, C., Rapino, B., Mc.Dermott, L. & Hadley, S., 2004, Comparison of the Semisolid Agar Antifungal Susceptibility Test with the NCCLS M38-P Broth Microdilution Test for Screening of Filamentous Fungi, Journal of Clinical Microbiology, 42 (3).
Lass-Florla, C., Koflera, G., Kropshoferc, G., Hermansd, J., Kreczyb, A., Diericha, M. P, et al., 1998, In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis, Journal of Antimicrobial Chemotherapy, 42.
Letscher-Bru, V. & Herbrecht, R., 2003, Caspofungin: the first representative of a new antifungal class, Journal of Antimicrobial Chemotherapy, 52.
Linares, M. J., Charriel, G., Sol’S, F., Rodriguez, J. R., Ibarra, A. & Casal, M., 2005, Susceptibility of Filamentous Fungi to Voriconazole Tested by Two Microdilution Methods, Journal of Clinical Microbiology, 43 (1).
Maertens, J., Raad, I., Petrikkos, G., Boogaerts, M., Selleslag, D., Petersen, F. B, et al., 2004, Efficacy and Safety of Caspofungin for Treatment of Invasive Aspergillosis in Patients Refractory to or Intolerant of Conventional Antifungal Therapy, Clinical Infectious Diseases, 39.
27
Mehrotra, R. S. & Aneja, K. R., 1990, An Introduction to Mycology, Wiley, New York, Wiley Eastern Limited.
Mellado, E., Alcazar-Fuoli, L., Cuenca-Estrella, M. & Rodriguez-Tudela, J.L., 2011, Role of Aspergillus lentulus 14-α Sterol Demethylase (Cyp51A) in Azole Drug Susceptibility, Antimicrobial Agents and Chemotherapy, 55 (12), 5459–5468.
Njunda, A. L., Ewang, A. A., Kamga, L. H. F., Nsagha, D. S., Assob, J. C., Ndah, D. A., et al., 2012, Respiratory Tract Aspergillosis in the Sputum of Patients Suspected of Tuberculosis in Fako Division-Cameroon, Journal of Microbiology Research, 2 (4), 68-72.
Oakley, K. L., Moore, C. B. & Denninga, D. W., 1998, In-vitro activity of voriconazole against Aspergillus spp. and comparison with itraconazole and amphotericin B, Journal of Antimicrobial Chemotherapy, 42.
Pasanen, A. L., 1991, Laboratory studies on the relationship between fungal growth and atmospheric temperature and humidity, Environment International, 17.
Penelope, D. B. & Kieren, A., 2006, Aspergillosis: Spectrum of Disease, Diagnosis, and Treatment, Infectious Disease Clinics of North America, 20.
Perea, S., Gonzales, G., Fothergill, A. W., Kirkpatrick, W. R., Rinaldi, M. & Patterson, T. F., 2002, In Vitro Interaction of Caspofungin Acetate with Voriconazole against Clinical Isolates of Aspergillus spp., Antimicrobial Agents and Chemotherapy, 46 (9).
Pfaller, M. A., Messer, S. A., Hollis, R. J. & Jones, R. N., 2002, Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of Aspergillus spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000, Antimicrobial Agents and Chemotherapy, 46 (4), 1032–1037.
Reiss, E., Shadomy, H.J. & Lyon, G.M., 2011, Fundamental Medical Mycology, New York, Wiley.
Siau, H. & Kerridge, A. D., 1998, The effect of antifungal drugs in combination on the growth of Candida glabrata in solid and liquid media, Journal of Antimicrobial Chemotherapy, 41.
28
Thompson, G. R. & Patterson, T. F., 2008, Pulmonary Aspergillosis, Seventh Avenue, New York, Thieme Medical Publishers, Inc.
Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., et al., 2008, Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America, IDSA Guidelines for Aspergillosis, 46.
